FORCE Conference

Managing Lymphedema: Education is the Best Treatment

October 22nd 2018, 12:00am

Article

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

Using Humor to Heal

October 21st 2018, 4:00pm

Article

Eva Moon shares nine habits for keeping a sense of humor when the going gets rough.

How to Have the Sex Talk During and After Cancer

October 21st 2018, 1:00am

Article

One expert shares advice for opening the line of communication between patients and health care providers, as well as their partners.

It's All in the Family: Discussing Cancer Risk with Extended Family Members

October 20th 2018, 10:11pm

Article

One family shares their experience with the discovery of a BRCA mutation, and how they discussed it among one another.

Movement, Moderation and Mindfulness: Being Proactive About Diet and Exercise

October 20th 2018, 8:58pm

Article

Exercise and nutrition are essential to improving a variety of facets revolving around the continuum of cancer — from prevention to diagnosis and treatment to survivorship care.

Clinical Trial Participation is Key for Hereditary Cancer Research Advancement

October 20th 2018, 4:31am

Article

Although individuals may have concerns about enrolling in a study, their involvement may lead to new discoveries.

Men with Genetic Mutations: What You Need to Know

October 20th 2018, 4:05am

Article

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

One Previvor's Journey With a BRCA Mutation

October 19th 2018, 11:58pm

Article

Eva Moon, a writer, musician and performing artist, discusses her genetic mutation and how it changed the direction of her life.

Previvor Turned Breast Cancer Survivor Shares Her Unexpected Journey

June 13th 2017, 12:18am

Article

Angela Schmidt Fishbaugh talks about being diagnosed with breast cancer after a mastectomy, changing her from a previvor to survivor.

Pairing PARP Inhibitors With Other Drug Types the Next Frontier for BRCA-Mutated Ovarian Cancers

June 11th 2017, 6:44pm

Article

The idea of interfering with DNA’s self-repair capabilities has been at the heart of this decade’s progress in treating ovarian cancer, and the focus now is on combining PARP inhibitors with other types of therapies.